Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report-Reference-Cited by-同舟云学术

Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report

Published:2019-02-07 Issue:2 Volume:32 Page:e12829
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Vico‐Alonso Cristina¹^ORCID,Calleja‐Algarra Alba¹,Aragón‐Miguel Raquel¹,Sánchez‐Velázquez Alba¹,Velasco‐Tamariz Virginia¹,Ortiz‐Romero Pablo Luis¹,Monsálvez‐Honrubia Verónica¹

Affiliation:

1. Dermatology and Venereology DepartmentHospital Universitario 12 de Octubre, Universidad Complutense de Madrid Madrid Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12829

Reference11 articles.

1. Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature

2. Successful management of severe infant bullous pemphigoid with omalizumab

3. Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

4. Bullous pemphigoid successfully treated with omalizumab

5. IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update;American Journal of Clinical Dermatology;2023-12-29

2. Research progress of omalizumab in the treatment of bullous pemphigoid;The Journal of Dermatology;2023-03-27

3. Bullous Pemphygoid and Novel Therapeutic Approaches;Biomedicines;2022-11-08

4. Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review;Frontiers in Immunology;2022-06-13

5. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients;Frontiers in Immunology;2022-04-20